Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B

De Ke Jiang, Xiao Pin Ma, Hongjie Yu, Guangwen Cao, Dong Lin Ding, Haitao Chen, Hui Xing Huang, Yu Zhen Gao, Xiao Pan Wu, Xi Dai Long, Hongxing Zhang, Youjie Zhang, Yong Gao, Tao Yang Chen, Wei Hua Ren, Pengyin Zhang, Zhuqing Shi, Wei Jiang, Bo Wan, Hexige Saiyin & 21 others Jianhua Yin, Yuan Feng Zhou, Yun Zhai, Pei Xin Lu, Hongwei Zhang, Xiaoli Gu, Aihua Tan, Jin Bing Wang, Xian Bo Zuo, Liang Dan Sun, Jun Liu, Qing Yi, Zengnan Mo, Gangqiao Zhou, Ying Liu, Jielin Sun, Yin Yao Shugart, S. Lilly Zheng, Xue Jun Zhang, Jianfeng Xu, Long Yu

Research output: Contribution to journalArticle

Abstract

Hepatitis B virus affects more than 2 billion people worldwide, 350 million of which have developed chronic hepatitis B (CHB). The genetic factors that confer CHB risk are still largely unknown. We sought to identify genetic variants for CHB susceptibility in the Chinese population. We undertook a genome-wide association study (GWAS) in 2,514 CHB cases and 1,130 normal controls from eastern China. We replicated 33 of the most promising signals and eight previously reported CHB risk loci through a two-stage validation totaling 6,600 CHB cases and 8,127 controls in four independent populations, of which two populations were recruited from eastern China, one from northern China and one from southern China. The joint analyses of 9,114 CHB cases and 9,257 controls revealed significant association of CHB risk with five novel loci. Four loci are located in the human leukocyte antigen (HLA) region at 6p21.3, including two nonsynonymous variants (rs12614 [R32W] in complement factor B [CFB], Pmeta=1.28 × 10-34; and rs422951 [T320A] in NOTCH4, Pmeta=5.33 × 10-16); one synonymous variant (rs378352 in HLA-DOA corresponding to HLA-DOA*010101, Pmeta=1.04 × 10-23); and one noncoding variant (rs2853953 near HLA-C, Pmeta=5.06 × 10-20). Another locus is located at 20q13.1 (rs1883832 in the Kozak sequence of CD40, Pmeta=2.95 × 10-15). Additionally, we validated seven of eight previously reported CHB susceptibility loci (rs3130542 at HLA-C, rs1419881 at TCF19, rs652888 at EHMT2, rs2856718 at HLA-DQB1, rs7453920 at HLA-DQB2, rs3077 at HLA-DPA1, and rs9277535 at HLA-DPA2, which are all located in the HLA region, 9.84 × 10-71≤Pmeta≤9.92 × 10-7). Conclusion: Our GWAS identified five novel susceptibility loci for CHB. These findings improve the understanding of CHB etiology and may provide new targets for prevention and treatment of this disease.

Original languageEnglish (US)
Pages (from-to)118-128
Number of pages11
JournalHepatology
Volume62
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Complement Factor B
Chronic Hepatitis B
HLA Antigens
China
Genome-Wide Association Study
Population
Hepatitis B virus
Joints

ASJC Scopus subject areas

  • Hepatology
  • Medicine(all)

Cite this

Jiang, D. K., Ma, X. P., Yu, H., Cao, G., Ding, D. L., Chen, H., ... Yu, L. (2015). Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B. Hepatology, 62(1), 118-128. https://doi.org/10.1002/hep.27794

Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B. / Jiang, De Ke; Ma, Xiao Pin; Yu, Hongjie; Cao, Guangwen; Ding, Dong Lin; Chen, Haitao; Huang, Hui Xing; Gao, Yu Zhen; Wu, Xiao Pan; Long, Xi Dai; Zhang, Hongxing; Zhang, Youjie; Gao, Yong; Chen, Tao Yang; Ren, Wei Hua; Zhang, Pengyin; Shi, Zhuqing; Jiang, Wei; Wan, Bo; Saiyin, Hexige; Yin, Jianhua; Zhou, Yuan Feng; Zhai, Yun; Lu, Pei Xin; Zhang, Hongwei; Gu, Xiaoli; Tan, Aihua; Wang, Jin Bing; Zuo, Xian Bo; Sun, Liang Dan; Liu, Jun; Yi, Qing; Mo, Zengnan; Zhou, Gangqiao; Liu, Ying; Sun, Jielin; Shugart, Yin Yao; Zheng, S. Lilly; Zhang, Xue Jun; Xu, Jianfeng; Yu, Long.

In: Hepatology, Vol. 62, No. 1, 01.07.2015, p. 118-128.

Research output: Contribution to journalArticle

Jiang, DK, Ma, XP, Yu, H, Cao, G, Ding, DL, Chen, H, Huang, HX, Gao, YZ, Wu, XP, Long, XD, Zhang, H, Zhang, Y, Gao, Y, Chen, TY, Ren, WH, Zhang, P, Shi, Z, Jiang, W, Wan, B, Saiyin, H, Yin, J, Zhou, YF, Zhai, Y, Lu, PX, Zhang, H, Gu, X, Tan, A, Wang, JB, Zuo, XB, Sun, LD, Liu, J, Yi, Q, Mo, Z, Zhou, G, Liu, Y, Sun, J, Shugart, YY, Zheng, SL, Zhang, XJ, Xu, J & Yu, L 2015, 'Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B', Hepatology, vol. 62, no. 1, pp. 118-128. https://doi.org/10.1002/hep.27794
Jiang, De Ke ; Ma, Xiao Pin ; Yu, Hongjie ; Cao, Guangwen ; Ding, Dong Lin ; Chen, Haitao ; Huang, Hui Xing ; Gao, Yu Zhen ; Wu, Xiao Pan ; Long, Xi Dai ; Zhang, Hongxing ; Zhang, Youjie ; Gao, Yong ; Chen, Tao Yang ; Ren, Wei Hua ; Zhang, Pengyin ; Shi, Zhuqing ; Jiang, Wei ; Wan, Bo ; Saiyin, Hexige ; Yin, Jianhua ; Zhou, Yuan Feng ; Zhai, Yun ; Lu, Pei Xin ; Zhang, Hongwei ; Gu, Xiaoli ; Tan, Aihua ; Wang, Jin Bing ; Zuo, Xian Bo ; Sun, Liang Dan ; Liu, Jun ; Yi, Qing ; Mo, Zengnan ; Zhou, Gangqiao ; Liu, Ying ; Sun, Jielin ; Shugart, Yin Yao ; Zheng, S. Lilly ; Zhang, Xue Jun ; Xu, Jianfeng ; Yu, Long. / Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B. In: Hepatology. 2015 ; Vol. 62, No. 1. pp. 118-128.
@article{d0a698b48aa34d93a4c08c37337425fe,
title = "Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B",
abstract = "Hepatitis B virus affects more than 2 billion people worldwide, 350 million of which have developed chronic hepatitis B (CHB). The genetic factors that confer CHB risk are still largely unknown. We sought to identify genetic variants for CHB susceptibility in the Chinese population. We undertook a genome-wide association study (GWAS) in 2,514 CHB cases and 1,130 normal controls from eastern China. We replicated 33 of the most promising signals and eight previously reported CHB risk loci through a two-stage validation totaling 6,600 CHB cases and 8,127 controls in four independent populations, of which two populations were recruited from eastern China, one from northern China and one from southern China. The joint analyses of 9,114 CHB cases and 9,257 controls revealed significant association of CHB risk with five novel loci. Four loci are located in the human leukocyte antigen (HLA) region at 6p21.3, including two nonsynonymous variants (rs12614 [R32W] in complement factor B [CFB], Pmeta=1.28 × 10-34; and rs422951 [T320A] in NOTCH4, Pmeta=5.33 × 10-16); one synonymous variant (rs378352 in HLA-DOA corresponding to HLA-DOA*010101, Pmeta=1.04 × 10-23); and one noncoding variant (rs2853953 near HLA-C, Pmeta=5.06 × 10-20). Another locus is located at 20q13.1 (rs1883832 in the Kozak sequence of CD40, Pmeta=2.95 × 10-15). Additionally, we validated seven of eight previously reported CHB susceptibility loci (rs3130542 at HLA-C, rs1419881 at TCF19, rs652888 at EHMT2, rs2856718 at HLA-DQB1, rs7453920 at HLA-DQB2, rs3077 at HLA-DPA1, and rs9277535 at HLA-DPA2, which are all located in the HLA region, 9.84 × 10-71≤Pmeta≤9.92 × 10-7). Conclusion: Our GWAS identified five novel susceptibility loci for CHB. These findings improve the understanding of CHB etiology and may provide new targets for prevention and treatment of this disease.",
author = "Jiang, {De Ke} and Ma, {Xiao Pin} and Hongjie Yu and Guangwen Cao and Ding, {Dong Lin} and Haitao Chen and Huang, {Hui Xing} and Gao, {Yu Zhen} and Wu, {Xiao Pan} and Long, {Xi Dai} and Hongxing Zhang and Youjie Zhang and Yong Gao and Chen, {Tao Yang} and Ren, {Wei Hua} and Pengyin Zhang and Zhuqing Shi and Wei Jiang and Bo Wan and Hexige Saiyin and Jianhua Yin and Zhou, {Yuan Feng} and Yun Zhai and Lu, {Pei Xin} and Hongwei Zhang and Xiaoli Gu and Aihua Tan and Wang, {Jin Bing} and Zuo, {Xian Bo} and Sun, {Liang Dan} and Jun Liu and Qing Yi and Zengnan Mo and Gangqiao Zhou and Ying Liu and Jielin Sun and Shugart, {Yin Yao} and Zheng, {S. Lilly} and Zhang, {Xue Jun} and Jianfeng Xu and Long Yu",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/hep.27794",
language = "English (US)",
volume = "62",
pages = "118--128",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Genetic Variants in Five Novel Loci Including CFB and CD40 Predispose to Chronic Hepatitis B

AU - Jiang, De Ke

AU - Ma, Xiao Pin

AU - Yu, Hongjie

AU - Cao, Guangwen

AU - Ding, Dong Lin

AU - Chen, Haitao

AU - Huang, Hui Xing

AU - Gao, Yu Zhen

AU - Wu, Xiao Pan

AU - Long, Xi Dai

AU - Zhang, Hongxing

AU - Zhang, Youjie

AU - Gao, Yong

AU - Chen, Tao Yang

AU - Ren, Wei Hua

AU - Zhang, Pengyin

AU - Shi, Zhuqing

AU - Jiang, Wei

AU - Wan, Bo

AU - Saiyin, Hexige

AU - Yin, Jianhua

AU - Zhou, Yuan Feng

AU - Zhai, Yun

AU - Lu, Pei Xin

AU - Zhang, Hongwei

AU - Gu, Xiaoli

AU - Tan, Aihua

AU - Wang, Jin Bing

AU - Zuo, Xian Bo

AU - Sun, Liang Dan

AU - Liu, Jun

AU - Yi, Qing

AU - Mo, Zengnan

AU - Zhou, Gangqiao

AU - Liu, Ying

AU - Sun, Jielin

AU - Shugart, Yin Yao

AU - Zheng, S. Lilly

AU - Zhang, Xue Jun

AU - Xu, Jianfeng

AU - Yu, Long

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Hepatitis B virus affects more than 2 billion people worldwide, 350 million of which have developed chronic hepatitis B (CHB). The genetic factors that confer CHB risk are still largely unknown. We sought to identify genetic variants for CHB susceptibility in the Chinese population. We undertook a genome-wide association study (GWAS) in 2,514 CHB cases and 1,130 normal controls from eastern China. We replicated 33 of the most promising signals and eight previously reported CHB risk loci through a two-stage validation totaling 6,600 CHB cases and 8,127 controls in four independent populations, of which two populations were recruited from eastern China, one from northern China and one from southern China. The joint analyses of 9,114 CHB cases and 9,257 controls revealed significant association of CHB risk with five novel loci. Four loci are located in the human leukocyte antigen (HLA) region at 6p21.3, including two nonsynonymous variants (rs12614 [R32W] in complement factor B [CFB], Pmeta=1.28 × 10-34; and rs422951 [T320A] in NOTCH4, Pmeta=5.33 × 10-16); one synonymous variant (rs378352 in HLA-DOA corresponding to HLA-DOA*010101, Pmeta=1.04 × 10-23); and one noncoding variant (rs2853953 near HLA-C, Pmeta=5.06 × 10-20). Another locus is located at 20q13.1 (rs1883832 in the Kozak sequence of CD40, Pmeta=2.95 × 10-15). Additionally, we validated seven of eight previously reported CHB susceptibility loci (rs3130542 at HLA-C, rs1419881 at TCF19, rs652888 at EHMT2, rs2856718 at HLA-DQB1, rs7453920 at HLA-DQB2, rs3077 at HLA-DPA1, and rs9277535 at HLA-DPA2, which are all located in the HLA region, 9.84 × 10-71≤Pmeta≤9.92 × 10-7). Conclusion: Our GWAS identified five novel susceptibility loci for CHB. These findings improve the understanding of CHB etiology and may provide new targets for prevention and treatment of this disease.

AB - Hepatitis B virus affects more than 2 billion people worldwide, 350 million of which have developed chronic hepatitis B (CHB). The genetic factors that confer CHB risk are still largely unknown. We sought to identify genetic variants for CHB susceptibility in the Chinese population. We undertook a genome-wide association study (GWAS) in 2,514 CHB cases and 1,130 normal controls from eastern China. We replicated 33 of the most promising signals and eight previously reported CHB risk loci through a two-stage validation totaling 6,600 CHB cases and 8,127 controls in four independent populations, of which two populations were recruited from eastern China, one from northern China and one from southern China. The joint analyses of 9,114 CHB cases and 9,257 controls revealed significant association of CHB risk with five novel loci. Four loci are located in the human leukocyte antigen (HLA) region at 6p21.3, including two nonsynonymous variants (rs12614 [R32W] in complement factor B [CFB], Pmeta=1.28 × 10-34; and rs422951 [T320A] in NOTCH4, Pmeta=5.33 × 10-16); one synonymous variant (rs378352 in HLA-DOA corresponding to HLA-DOA*010101, Pmeta=1.04 × 10-23); and one noncoding variant (rs2853953 near HLA-C, Pmeta=5.06 × 10-20). Another locus is located at 20q13.1 (rs1883832 in the Kozak sequence of CD40, Pmeta=2.95 × 10-15). Additionally, we validated seven of eight previously reported CHB susceptibility loci (rs3130542 at HLA-C, rs1419881 at TCF19, rs652888 at EHMT2, rs2856718 at HLA-DQB1, rs7453920 at HLA-DQB2, rs3077 at HLA-DPA1, and rs9277535 at HLA-DPA2, which are all located in the HLA region, 9.84 × 10-71≤Pmeta≤9.92 × 10-7). Conclusion: Our GWAS identified five novel susceptibility loci for CHB. These findings improve the understanding of CHB etiology and may provide new targets for prevention and treatment of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84933179399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933179399&partnerID=8YFLogxK

U2 - 10.1002/hep.27794

DO - 10.1002/hep.27794

M3 - Article

VL - 62

SP - 118

EP - 128

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -